The current role and perceived benefits and barriers of secondary care pharmacists facilitating patient participation in Clinical Trials of Investigational Medicinal Products (CTIMPs) conducted within the NHS: A cross‐sectional survey

Watson, M, Bewick, BM orcid.org/0000-0001-5752-5623 and Tharmanathan, P (2020) The current role and perceived benefits and barriers of secondary care pharmacists facilitating patient participation in Clinical Trials of Investigational Medicinal Products (CTIMPs) conducted within the NHS: A cross‐sectional survey. Journal of Evaluation in Clinical Practice, 26 (1). pp. 142-148. ISSN 1356-1294

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Watson, M, Bewick, BM, Tharmanathan, P. The current role and perceived benefits and barriers of secondary care pharmacists facilitating patient participation in Clinical Trials of Investigational Medicinal Products (CTIMPs) conducted within the NHS: A cross‐sectional survey. J Eval Clin Pract. 2020; 26: 142– 148, which has been published in final form at https://doi.org/10.1111/jep.13104. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: health services research
Dates:
  • Published: February 2020
  • Accepted: 4 January 2019
  • Published (online): 28 January 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Psychiatry and Behavioural Sciences (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 28 Jan 2019 11:00
Last Modified: 30 Jan 2020 16:25
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/jep.13104

Share / Export

Statistics